Conference Coverage

Surgery indicates higher survival with adrenal cortical carcinoma

Publish date: March 17, 2018

 

REPORTING FROM ENDO 2018

A more robust database and future stage-specific, prospective clinical trials are needed in order to better understand these findings, Dr. Tella said.

The investigators reported no relevant financial disclosures.

SOURCE: Tella SH et al. Endo 2018.

Pages

Recommended Reading

Temozolomide may help half of patients with aggressive pituitary tumors
MDedge Hematology and Oncology
USPSTF: No thyroid cancer screening for asymptomatic adults
MDedge Hematology and Oncology
VIDEO: Less follow-up proposed for low-risk thyroid cancer
MDedge Hematology and Oncology
Thyroid-nodule size boosts serum thyroglobulin’s diagnostic value
MDedge Hematology and Oncology
Contralateral nodal thyroid metastases show slow progression
MDedge Hematology and Oncology
Big changes coming for thyroid cancer staging
MDedge Hematology and Oncology
AML risk is doubled in low-risk thyroid cancer patients unnecessarily given radioactive iodine therapy
MDedge Hematology and Oncology
Papillary thyroid microcarcinoma: Is ‘less is more’ the right approach?
MDedge Hematology and Oncology
Cancer patients with TKI-induced hypothyroidism had better survival rates
MDedge Hematology and Oncology
New and improved classifiers may sharpen thyroid nodule diagnosis
MDedge Hematology and Oncology